We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+2.28%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$5.09B
AUM Growth
+$263M
Cap. Flow
+$193M
Cap. Flow %
3.79%
Top 10 Hldgs %
40.89%
Holding
114
New
34
Increased
24
Reduced
18
Closed
26

Top Buys

Rank Stock Value
1
CHTR icon
Charter Communications
CHTR
+$186M
2
YHOO
Yahoo Inc
YHOO
+$160M
3
SWY
SAFEWAY INC
SWY
+$132M
4
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$106M
5
FWLT
FOSTER WHEELER AG (SWITZERLAND)
FWLT
+$102M

Top Sells

Rank Stock Value
1
LPS
LENDER PROCESSING SERVICES INC
LPS
+$159M
2
HMA
HEALTH MGMT ASSOC INC CL-A
HMA
+$144M
3
AGN
Allergan plc
AGN
+$110M
4
STZ icon
Constellation Brands
STZ
+$99.4M
5
EMC
EMC CORPORATION
EMC
+$92.8M

Sector Composition

Rank Sector Weight
1 Communication Services 18.94%
2 Consumer Discretionary 13.67%
3 Real Estate 10.68%
4 Consumer Staples 10%
5 Industrials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCK icon
51
McKesson
MCK
$100B
$15.3M 0.3%
+86,500
New +$15.1M
HELI
52
DELISTED
CHC GROUP LTD SHS NEW (CYM)
HELI
$13.5M 0.26%
+60,833
New +$16.3M
RCPT
53
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$13M 0.26%
310,000
+300,000
+3,000% +$12.9M
RPRX
54
DELISTED
Repros Therapeutics Inc.
RPRX
$12.4M 0.24%
700,000
– –
OCIP
55
DELISTED
OCI Partners LP
OCIP
$10.7M 0.21%
500,000
– –
VIRX
56
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$10.6M 0.21%
7,619
+2,619
+52% +$3.05M
ITMN
57
DELISTED
INTERMUNE INC
ITMN
$10M 0.2%
+300,000
New +$6.68M
ANAC
58
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$10M 0.2%
500,000
-62,352
-11% -$1.21M
CYH icon
59
Community Health Systems
CYH
$424M
$9.79M 0.19%
+302,500
New +$9.99M
PCO
60
DELISTED
Pendrell Corporation - Class A
PCO
$9.69M 0.19%
5,293
+329
+7% +$530K
PWRD
61
DELISTED
PERFECT WORLD CO LTD SPONSORED ADR REPSTG CL B (CAYMAN ISL)
PWRD
$8.16M 0.16%
+395,000
New +$8.2M
TTM
62
DELISTED
Tata Motors Limited
TTM
$6.99M 0.14%
197,514
– –
FRED
63
DELISTED
Fred's Inc
FRED
$6.75M 0.13%
+375,000
New +$6.92M
CPF icon
64
Central Pacific Financial
CPF
$964M
$6.18M 0.12%
+306,042
New +$5.99M
EIGR
65
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$3.24M 0.06%
+604
New +$2.85M
FATE icon
66
Fate Therapeutics
FATE
$279M
$2.68M 0.05%
275,000
-269,243
-49% -$2.08M
ARQL
67
DELISTED
Arqule Inc
ARQL
$2.58M 0.05%
1,258,732
-205,967
-14% -$462K
IBP icon
68
Installed Building Products
IBP
$6.56B
$2.5M 0.05%
+178,824
New +$2.47M
PACT
69
DELISTED
PACTERA TECHNOLOGY INTL LTD SPONSORED ADR
PACT
$2.28M 0.04%
314,006
+151,197
+93% +$1.08M
NKTR icon
70
Nektar Therapeutics
NKTR
$2.53B
$2.24M 0.04%
12,333
-28,334
-70% -$5.61M
GLCH
71
DELISTED
GLEACHER & CO INC COM NEW (NY)
GLCH
$2.19M 0.04%
+192,093
New +$2.15M
STML
72
DELISTED
Stemline Therapeutics, Inc.
STML
$1.93M 0.04%
95,000
– –
ACAD icon
73
Acadia Pharmaceuticals
ACAD
$5.08B
$1.7M 0.03%
+70,000
New +$1.77M
NCLH icon
74
Norwegian Cruise Line
NCLH
$7.92B
$1.61M 0.03%
+50,000
New +$1.71M
MACK
75
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$1.6M 0.03%
40,331
-62,025
-61% -$2.65M
1 2
3
4 5

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q1 2014 Portfolio in Review

As of Q1 2014, Thomas Steyer held 114 positions worth $5.09B, up 5.4% from $4.83B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Thomas Steyer deployed $193M of net new capital in Q1 2014, opening 34 new positions and adding to 24 existing holdings. Its largest new stake was SAFEWAY INC: 4,254,541 shares worth $141M.

By sector, the portfolio is most concentrated in Communication Services at 19% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Real Estate.

On the sell side, the largest reduction was TIME WARNER CABLE INC NEW COM STK, an estimated $82.6M trimmed.

  • Thomas Steyer's largest Q1 2014 buy was SAFEWAY INC: 4,254,541 shares worth $141M.
  • Thomas Steyer added most to Charter Communications in Q1 2014, an estimated $186M increase.
  • Thomas Steyer's biggest Q1 2014 reduction was TIME WARNER CABLE INC NEW COM STK, cutting an estimated $82.6M.
  • Thomas Steyer fully exited LENDER PROCESSING SERVICES INC in Q1 2014, selling an estimated $159M.
  • Thomas Steyer's ten largest holdings make up 41% of its $5.09B portfolio in Q1 2014.
  • Thomas Steyer opened 34 new positions and closed 26 in Q1 2014.
  • Thomas Steyer's portfolio value rose 5.4% quarter-over-quarter to $5.09B.

Based on Farallon Capital Management's 13F filing for Q1 2014, filed 15 May 2014.